New hypothesis and treatment targets of depression:an integrated view of key findings

被引:8
作者
Shangli Cai
Shucai Huang
Wei Hao
机构
[1] MentalHealthInstituteandKeyLaboratoryofPsychiatryofHunanProvince,TheSecondXiangyaHospital,CentralSouthUniversity
关键词
depression; BDNF; cytokines; hypothalamus-pituitary-adrenal axis; glutamate receptor;
D O I
暂无
中图分类号
R749.4 [情感性精神病];
学科分类号
100205 ;
摘要
Major depressive disorder(MDD) is a common and devastating psychiatric disorder characterized by persistent low mood,cognitive disorder,and impaired social function. Despite its complex mechanisms,increasing evidence has identified the involvement of neurotrophic factors,inflammatory cytokines,the hypothalamuspituitary-adrenal axis,and glutamate receptors in the pathophysiology of this illness. The present review synthesizes recent research achievements to defi ne the network between different hypotheses of MDD and to understand which part is most pivotal for its pathogenesis. By integrating MDD-related signal pathways,we highlight brain-derived neurotrophic factor(BDNF) dysfunction and increased apoptosis as the fi nal common cascades,and new therapeutic strategies aiming to enhance BDNF function have been shown to exert a rapid and effective antidepressant action.
引用
收藏
页码:61 / 74
页数:14
相关论文
共 49 条
[1]   Inflammation: a mechanism of depression? [J].
Qiu-Qin Han ;
Jin Yu .
NeuroscienceBulletin, 2014, 30 (03) :515-523
[2]  
Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis[J] . Kyoung-Sae Na,Kang Joon Lee,Ji Sung Lee,Young Sung Cho,Han-Yong Jung.Progress in Neuropsychopharmacology & Biological Psychiatry . 2014
[3]  
A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers[J] . Adrian L. Lopresti,Garth L. Maker,Sean D. Hood,Peter D. Drummond.Progress in Neuropsychopharmacology & Biological Psychiatry . 2014
[4]  
GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists[J] . Joseph R Moskal,Ronald Burch,Jeffrey S Burgdorf,Roger A Kroes,Patric K Stanton,John F Disterhoft,J David Leander.Expert Opinion on Investigational Drugs . 2014 (2)
[5]  
Glucocorticoid receptor activation impairs hippocampal plasticity by suppressing BDNF expression in obese mice[J] . Marlena Wosiski-Kuhn,Joanna R. Erion,Elise P. Gomez-Sanchez,Celso E. Gomez-Sanchez,Alexis M. Stranahan.Psychoneuroendocrinology . 2014
[6]   Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia [J].
Zugno, Alexandra I. ;
Juliao, Ricardo Filipe ;
Budni, Josiane ;
Volpato, Ana Maria ;
Fraga, Daiane B. ;
Pacheco, Felipe D. ;
Deroza, Pedro F. ;
Luca, Renata D. ;
de Oliveira, Mariana B. ;
Heylmann, Alexandra S. ;
Quevedo, Joao .
METABOLIC BRAIN DISEASE, 2013, 28 (03) :501-508
[7]  
Ketamine, Sleep, and Depression: Current Status and New Questions[J] . Wallace C. Duncan,Carlos A. Zarate.Current Psychiatry Reports . 2013 (9)
[8]   The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine [J].
Monteggia, Lisa M. ;
Gideons, Erinn ;
Kavalali, Ege T. .
BIOLOGICAL PSYCHIATRY, 2013, 73 (12) :1199-1203
[9]   Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner [J].
Zhang, Jia ;
Fan, Yan ;
Li, Ying ;
Zhu, Hobart ;
Wang, Liang ;
Zhu, Meng-Yang .
JOURNAL OF NEUROCHEMISTRY, 2012, 123 (06) :1054-1068
[10]  
Brain‐derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/β‐catenin signaling pathway[J] . Bei‐Yu Chen,Xi Wang,Zhao‐Yan Wang,Ya‐Zhou Wang,Liang‐Wei Chen,Zhuo‐Jing Luo.J. Neurosci. Res. . 2012 (1)